Skip to content

Agilent Technologies A Restricted Cash

Restricted Cash at other companies

Twist Bioscience Corporation logo
Twist Bioscience CorporationTWST
$2.18M-13.1%
AVT
AvantorAVTR
$2.9M+3.6%
Revvity logo
RevvityRVTY
Thermo Fisher Scientific logo
Thermo Fisher ScientificTMO
Bruker logo
BrukerBRKR
Bio-Rad Laboratories logo
Bio-Rad LaboratoriesBIO

Other financials

Income statement

See full
Revenue$1.8B+10.0%
Gross profit$990.0M+14.3%
Operating income$399.0M+33.0%
Net income$339.0M+57.7%
EPS (diluted)$1.20+60.0%

Balance sheet

See full
Cash & equivalents$1.8B+21.5%
Total debt$3.5B-3.9%
Total equity$7.1B+16.1%
Total assets$13.1B+7.5%

Cash flow

See full
Operating cash flow$277.0M+25.3%
CapEx$76.0M-33.3%
Free cash flow$201.0M+87.9%

Valuation

See full
Market cap$37.52B+8.8%
Enterprise value$39.25B+7.0%
P/E26.5×-3.0×
P/S5.2×0.0×

Profitability

See full
Gross margin52.7%-0.6pp
Operating margin21.5%+0.1pp
Net margin19.6%+2.0pp
FCF margin15%-2.9pp

Returns & leverage

See full
Return on equity21.3%+2.4pp
Debt / equity0.5×-0.1×
Current ratio2.1×0.0×

Where this comes from

Reported directly by Agilent Technologies in its filing.

Tagged under the XBRL concept us-gaap:RestrictedCash.

The official record: Agilent Technologies’s 10-Q, filed June 1, 2026, on SEC EDGAR. View the filing →

Ask your AI about Agilent Technologies's restricted cash.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Agilent Technologies's restricted cash?
Agilent Technologies (A) reported restricted cash of $2M in Q1 2026.
How has Agilent Technologies's restricted cash changed year-over-year?
Agilent Technologies's restricted cash decreased by 33.3% year-over-year, from $3M to $2M.
What is the long-term trend for Agilent Technologies's restricted cash?
Over 5 years (2020 to 2025), Agilent Technologies's restricted cash has grown at a -19.7% compound annual growth rate (CAGR), from $6M to $2M.
What does restricted cash mean?
Cash restricted for specific purposes by contractual, regulatory, or legal requirements — not available for general corporate use.